您是否有腋下多汗的困擾?
Do you have trouble of underarm sweating?
什麼是腋下多汗?
What is hyperhidrosis?
汗腺具有散熱、調節體溫的功能。當汗腺因為受到刺激而過度分泌時，就會造成腋下多汗19，導致生活上諸多不便。
Sweat glands are responsible for cooling and regulation of body temperature. When sweat glands are over-secreted due to stimulation, it will cause underarm hyperhidrosis19, bringing inconvenience to lives.
你有以下狀況嗎？
Do you have below conditions?
只要稍微活動
腋下兩側便大量出汗
Both sides of underarm
will sweat much even
doing little exercise
腋下多汗
讓我感覺尷尬
Underarm sweating
makes me feel
embarrassed
家族歷史中有多汗狀況
Family history of
hyperhidrosis
多汗造成異味
影響社交與日常生活
Odor caused by sweating
affects social and daily lives
若你有以上狀況建議你立即向醫生諮詢療程細節
If you experience above conditions, it is suggested to consult your doctors for treatment
BOTOX®保妥適®止汗原理20,21
BOTOX® Mechanism of Action to
reduce underarm sweating20,21
治療前，汗腺受到訊號刺激，分泌汗水。
Before treatment, sweat glands are stimulated by signals and facilitates sweating
治療後，抑制刺激，減少汗水分泌20,21。
After treatment, sweating is reduced due to signal blocking20,21
於皮下注射BOTOX®保妥適®，可抑制神經末梢釋放神經傳導物乙醯膽鹼，
阻斷與汗腺的信號傳遞，進而抑制汗水分泌20,21。
Subcutaneous injection of BOTOX® inhibits the release of the
neurotransmitter acetylcholine from the nerve endings, blocking signal
transmission, and thus inhibit sweating20,21.
擺脫腋汗困擾 享受乾爽夏日
Reduce severe underarm sweating
療程簡單且低創傷性
Simple and minimal invasive treatment
BOTOX®保妥適®止汗療程創傷性低，過程簡單且藥效持久，能有效減低腋下汗水產生及因多汗潮濕而導致的腋下異味22。
BOTOX® treatment is simple and non-invasive. It provides long term relief of sweating and reduces body odor caused by sweating22.
療程後一週，95%用家認同有效23
95% patients agree to obtain obvious result in sweat reduction one week after treatment23.
進行BOTOX®保妥適®止汗療程
一週後出汗率減少83%23
According to a clinical study, patients receiving BOTOX® treatment achieved an 83% reduction in sweating after 1 week23
一次進行BOTOX®保妥適®止汗
療程的效果可維持205天24
Result last up to 205 days after one treatment24
BOTOX®保妥適®
與其他止汗療程的分別What makes BOTOX® different from others
BOTOX®保妥適®
BOTOX®保妥適®療程只需10-15分鐘，過程簡單而藥效持久，也不需要全身麻醉，免除住院的麻煩。 BOTOX® treatment is simple and provides long term relief of sweating. It only takes 10-15 minutes and no anesthesia or hospitalization is required.
止汗劑 Antiperspirants
效果短暫，需不斷地重複塗抹，已混和了止汗劑的汗腋亦會產生異味。 Only short-term relief of sweating can be achieved and repeated applications are needed. Body odor occurs when sweat mixes with antiperspirants.
切除汗腺外科手術 Surgery to remove sweat glands
具創傷性，有機會令膚色加深或形成疤痕，相對地費用較昂貴，復發機會高，亦有機會出現代償性出汗的後遺症24。 It involves invasive that may cause darker skin or scars and is relatively more expensive. High recurrence rate and compensatory sweating may also occur24.
BOTOX®保妥適®
BOTOX®保妥適®療程只需10-15分鐘，過程簡單而藥效持久，也不需要全身麻醉，免除住院的麻煩。 BOTOX® treatment is simple and provides long term relief of sweating. It only takes 10-15 minutes and no anesthesia or hospitalization is required.
‡: Medical Insight, Inc 2018. Global Facial Injectables Market Study. December 2018. Based on worldwide neurotoxins market 2017 (in sales value).
*: Allergan. Unpublished Data. INT/0292/2018(1). March 2019. #: BOTOX® Prescribing Information. HK-41906. May 2013.
†: Allergan. Data on File. REF-74184.UNPUBLISHED DATA: BOTOX® number of vials shipped as of March 2019 INT/0292/2018(1). March 2019.
References: 1. Trindade de Almeida A et al. Dermatol Surg 2015; 41: S19-S28. 2. Yu W et al. J Cosmet Laser Ther. 2018Oct;20(5):278-286. 3. U.S. Food and Drug Administration, Department of Health & Human Services. Botox approval letter 85-0226 & 85-0227, December 29, 1989. 4. Allergan. Unpublished Data. INT-BCT-2050129 – Worldwide BOTOX® marketing authorization status. October 2020. 5. Allergan. Unpublished Data. INT-BCT-2050035. BOTOX® vs competitors – number of peer reviewed articles vs competitors. February 2020. 6. Flaharty, P. (2014, April 8). Your facial wrinkles are dynamic or static. Retrieved February 10, 2022, from https://www.news-press.com/story/life/wellness/2014/04/08/beauty-tips-your-facial-wrinkles-are-dynamic-or-static/7432785/. 7. DasGupta BR. Structures of botulinum neurotoxin, its functional domains, and perspectives on the crystalline type A toxin. In: Jankovic J, Hallet, M., ed. Therapy with Botulinum Toxin. New York, NY: Marcel Decker, Inc; 1994: 15-39. 8. Coffield JA, Considine RV, Simpson LL. The site and mechanism of action of botulinum neurotoxin. In: Jankovic J, Hallet, M., ed. Therapy with Botulinum Toxin. New York, NY: Marcel Dekker, Inc; 1994:3-13. 9. Schantz EJ, Johnson EA. Preparation and characterization of botulinum toxin type A for human treatment. In: Jankovic J, Hallet, M., ed. Therapy with Botulinum Toxin. New York, NY: Marcel Dekker, Inc; 1994:41-49. 10. Simpson LL. The actions of clostridial toxins on storage and release of neurotransmitters. In: Harvey AL, ed. Natural and Synthetic Neurotoxins (Neuroscience Perspectives). San Diego, CA: Academic Press; 1993:278-317. 11. Black JD, Dolly JO. Interaction of 125I-labeled botulinum neurotoxins with nerve terminals II. Autoradiographic evidence for its uptake into motor nerves by acceptor-mediated endocytosis. J Cell Biol. 1986;103(2):535-544. 12. Lebeda FJ, Hack DC, Bentry MK. Theoretical analyses of the functional regions of the heavy chain of botulinum neurotoxin. In: Jankovic J, Hallet M, ed. Therapy with Botulinum Toxin. New York, NY: Marcel Dekker, Inc; 1994:51-61. 13. Harvey AL. Presynaptic toxins. In: Smythies JR, Bradley RJ, ed. International Review of. 14. Neurobiology. San Diego, CA: Academic Press; 1990:201-239. 15. Tremaine AM, McCullough JL. Clin Cosmet Investig Dermatol. 2010;3:15–23. 16. Stotland MA et al. Plast Reconstr Surg 2007; 120(5):1386-9. 17. Beer KR et al. J Drugs Dermatol 2011;10:39-41. 18. De Boulle K et al. Dermatol Surg. 2018;44[11]:1437-1448. 19. Hyperhidrosis- Causes and Treatment of Enhanced Sweating. Dtsch Arztebl Int. 2009 Jan; 106(3):32-37. 20. Aesthetic Surg J. 2012 Feb;32(2):238-244. 21. J Am Acad Dermatol. 2007 Apr; 56(4):604-11. 22. He J, Wang T and Dong J. Journal of Dermatological Treatment. 2012 23: 461–464. 23. Naumann M and Lowe NJ. BMJ 2001;323:1–4. 24. Lowe NJ et al. J Am Acad Dermatol. 2007;56(4):604-611. 25. U.S. Food and Drug Administration, Department of Health & Human Services. Botox approval letter SUPPL-5303, October 2, 2017.
BOTOX®保妥適®(Botulinum Toxin Type A)藥品註冊編號: HK-41906. BOTOX®為醫生處方藥物，請向醫生或醫學美容中心
諮詢切合您獨特需要的專屬療程方案。療程效果因人而異。療程後如有任何不良反應，請即向醫生查詢
© 2023 Allergan Aesthetics. All rights reserved. All adverse events should be reported to drugsafety.pv@abbvie.com. HK-BCT-230023.
Approval date: 23/Mar/23
香港北角電氣道 183 號友邦廣場 24 樓 2404-08 室 電話: (852)26102525
